CMR outcomes following one-time in vivo CRISPR editing with nexiguran ziclumeran in patients with ATTR-CM: phase 1 results
11 May 2026 (16:53 - 17:02)
Organised by: 
About the speaker
University College London, London (United Kingdom of Great Britain & Northern Ireland)
6 More presentations in this session
Doctor V. Algalarrondo (Paris, FR)
Doctor A. Abovich (Boston, US)
Access the full session
The Event
Heart Failure 2026
11 May 2026
16:53 CET
You may be interested in
Congress Session
Congress Session
